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Escherichia coli F-18 is a human fecal isolate that makes type 1 fimbriae, encoded by the fim gene cluster, and
is an excellent colonizer of the streptomycin-treated mouse intestine. E. coli F-18 fimA::tet, lacking type 1 fim-
briae, was constructed by bacteriophage P1 transduction of the fim region of the E. coli K-12 strain ORN151,
containing the tetracycline resistance gene from Tn10 inserted in the fimA gene, into E. coli F-18. E. coli F-18
fimA::tet was found to occupy a distinct niche in the streptomycin-treated mouse intestine when fed in small
numbers (104 CFU) to mice, along with large numbers (1010 CFU) of E. coli F-18, as defined by the ability of
the E. coli F-18 fimA::tet strain to grow and colonize only 1 order of magnitude below E. coli F-18. The same
effect was observed when mice already colonized with E. coli F-18 were fed small numbers of E. coli F-18 fimA::
tet. Experiments which show that the E. coli K-12 gene responsible for this effect is not fim::tet but gntP, which
maps immediately downstream of the fim gene cluster, are presented. gntP encodes a high-affinity gluconate
permease, suggesting that the distinct niche in themouse large intestine is defined by the presence of gluconate. The
data presented here support the idea that small numbers of an ingested microorganism can colonize the
intestine as long as it can utilize an available nutrient better than any of the other resident species can.
A thick (200- to 400-mm), viscous mucus layer covers the
epithelial cells of the mammalian large intestine (1, 11). The
mucus layer consists of mucin (a gel-forming glycoprotein),
glycoproteins, lipids, proteins, nucleic acids, epithelial cell de-
bris, enzymes, bile, and all the components of gastric juices (1,
25). The mucus layer is thought to exist in a dynamic state in
which the mucus is continuously being secreted by goblet cells
and simultaneously being degraded by the resident microor-
ganisms (23, 36).
An examination of the mammalian intestine has revealed
that several hundred species of microorganisms inhabit this
environment (35). The diversity of microorganisms reflects
their respective abilities to occupy different ecological niches.
It has been demonstrated in experiments in chemostats that
two different microorganisms having a preference for the same
growth-limiting nutrient cannot coexist (41). That is, one will
eventually outcompete and eliminate the other. However, if
two different microorganisms utilize different growth-limiting
nutrients, they can coexist in a chemostat and maintain stable
populations (44, 46). These observations have led to the theory
that the mammalian intestine may be thought of as a chemo-
stat with several hundred species in equilibrium, each utilizing
a different limiting nutrient better than all the other species
(19, 30). The size of any particular population would then be
dependent on and proportional to the concentration of the
corresponding nutrient. The plethora of substrates present in
the intestinal tract arise from ingested and digested food,
epithelial cell debris, mucus, and substrates secreted by the
microflora. An exception to this nutrient/niche theory was de-
veloped by Freter, who used mathematical modeling to dem-
onstrate that two species competing for the same limiting nu-
trient may occupy the same niche if the less efficient species
can adhere to the intestinal mucosa (20). Thus, two classes of
ecological niches may exist in the intestine, specific adhesion
niches and specific nutrient niches.
Although many species of bacteria found in the mammalian
large intestine have been characterized and cataloged, rela-
tively little is known about how they compete with each other
nutritionally, i.e., which substrates are available to support
growth, which metabolic pathways are used, and which genes
are required for the ability to colonize. A major problem en-
countered in studying the colonization of the mammalian in-
testine is what is commonly referred to as “colonization resis-
tance,” in which all intestinal niches are occupied in a balanced
ecosystem and most ingested microorganisms fail to colonize
because of the lack of an available niche. This phenomenon,
predicted by the theories described above, has been noted by
several extensive studies (8, 9, 17, 18, 45). For example, when
human volunteers were fed with E. coli K-12 strains, these
strains did not persist in the feces of these individuals (2,
32, 43). Moreover, when healthy human volunteers were fed E.
coli strains isolated from their own feces, even those strains
could not colonize (3).
Despite the phenomenon of colonization resistance, a con-
tinuous succession of E. coli strains appears to exist in the
mammalian intestine. Some strains are present for extended
periods from months to years (residents), whereas others
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(transients) can be detected for only several days (38–40). In
one study in which the plasmid profiles of different E. coli
strains in fecal samples obtained from one person were exam-
ined during an 11-month period, 53 different electrophoretic
types were found, and although most were detected for only a
few sampling days, some were present for extended periods
(12). In another study, an average of five E. coli biotypes were
found in the feces of individual humans (4). Thus, diversity
exists even among normal commensal E. coli strains in the
intestine, suggesting the possibility that different E. coli strains
utilize different growth-limiting nutrients for colonization.
In the present study, we present a situation in which an E.
coli K-12 fim-linked gene allows E. coli F-18, a normal human
fecal isolate (13), to occupy a distinct niche in the mouse large
intestine, as defined by its ability, when ingested in small num-
bers, to grow and colonize in the presence of large numbers of
its parent. Moreover, we show that the E. coli K-12 fim-linked
gene is gntP, a recently described gene which encodes a high-
affinity gluconate permease (28).
MATERIALS AND METHODS
Bacterial strains and plasmids. All the E. coli F-18 and K-12 strains and
plasmids used in this study are listed in Table 1.
Bacteriophage P1 transduction. All P1 transductions were performed as pre-
viously described (34).
Construction of E. coli F-18 strain 167 uxuA::miniTn10::npt. E. coli F-18 strain
167 uxu A::miniTn10::npt, which is unable to metabolize glucuronate, was con-
structed by insertional mutagenesis (14, 22). E. coliATM160, carrying the suicide
vector pLOF, was conjugated with E. coli F-18 no. 167 (Table 1) in the following
manner. Recipient and donor strains were grown overnight in Luria broth with
shaking at 308C. Aliquots of 100 ml of each culture were mixed in 5 ml of 10 mM
MgSO4 and filtered through a Millipore 0.45-mm-pore-size membrane filter. The
filter was placed on the surface of a Luria agar plate and incubated for 5 h at
378C. Following incubation, cells on the filter were suspended in 5 ml of 10 mM
MgSO4, and 100-ml aliquots of the suspension were plated on Luria agar con-
taining streptomycin (100 mg/ml) and kanamycin sulfate (80 mg/ml). The result-
ing colonies (approximately 2,000) were then toothpicked onto Davis minimal
agar plates containing either glucose (1 mg/ml), glucuronate (2.5 mg/ml), glu-
conate (2.5 mg/ml), or galacturonate (2.5 mg/ml). One colony grew on glucose,
gluconate, and galacturonate but not glucuronate. The strain was sensitive to
ampicillin (100 mg/ml), eliminating the possibility that pLOF integrated into the
chromosome. When this strain was complemented with pRU6 (containing a
functional uxuA gene), glucuronate metabolism was restored (Table 2). Plasmid
pJVN27 (control vector) did not restore glucuronate metabolism. The strain was
designated E. coli F-18 no. 167 uxuA::miniTn10::npt.
The uxuA gene maps at 98.1 min on the E. coli K-12 chromosome (6), down-
stream of the fim gene cluster. To confirm the location of the uxuA::miniTn10::
npt mutation, the cotransduction frequency of fim and uxuA::miniTn10::npt from
E. coli F-18 no. 167 uxuA::miniTn10::npt to E. coli K-12 was determined. Eigh-
teen E. coli K-12 uxuA::miniTn10::npt transductants (kanamycin resistant and
unable to utilize glucuronate as the sole carbon source but able to utilize glucose,
gluconate, or galacturonate) were tested for the fim region of E. coli F-18 no. 167
uxuA::miniTn10::npt (marked with tet, [Table 1]). As expected for closely linked
genes, 12 of the 18 E. coli K-12 uxuA::miniTn10::npt transductants (67%) were
tetracycline resistant.
DNA techniques. E. coli HB101 (10) was transformed with plasmids via elec-
troporation with a gene pulser (Bio-Rad Laboratories, Richmond, Calif.). Plas-
mids were isolated from transformed E. coliHB101 on Promega Magic miniprep
columns (Promega Corp., Madison, Wis.) and subsequently electroporated into
E. coli F-18 and K-12 strains.
Agglutination of E. coli F-18 strains by rabbit-specific anti-type 1 fimbria
serum. All E. coli F-18 strains used in this study were tested for the presence of
type 1 fimbriae after growth to stationary phase at 378C in Luria broth. Aliquots
of 100 ml of each culture were added to 10 ml of undiluted rabbit-specific
anti-type 1 fimbria serum (34) for 5 min at room temperature, and the mixtures
were observed by phase-contrast microscopy (magnification, 3400 for the extent
of agglutination). The antiserum was preadsorbed with whole E. coli fimA::tet to
prevent nonspecific binding of antibodies to the test cells.
Mouse colonization experiments. The method used to compare the relative
TABLE 1. E. coli strains and plasmids used in this study
Strain or plasmid Relevent characteristics Source orreference
Strains
F-18 Strr Rifr 13
F-18 Nalr Strr Rifr Nalr 34
F-18 fimA::tet Transduction of fimA::tet from ORN151 to F-18, Strr Rifr Tetr 34
F-18 fimA::npt Transduction of fimA::npt from ORN147 to F-18, Strr Rifr Kanr This study
F-18 no. 99 Transduction of fim region from ORN174 to F-18 fimA::npt; Strr Rifr Tetr This study
F-18 no. 167 Transduction of fim region from ORN174 to F-18 fimA::npt; Strr Rifr Tetr This study
F-18 no. 167 uxuA::miniTn10::npt miniTn10::npt into uxuA of F-18 no. 167, Strr Rifr Tetr Kanr This study
ORN151 rpsL fimA::tet, Strr Tetr 33
ORN147 rpsL fimA::npt, Strr Kanr 33
ORN174 tet inserted 400 bp downstream of fimH 7
ATM160 lpir, contains pLOF 14, 22
Plasmids
pRU1 fimF fimG fimH gntP uxuA uxuB E. coli K-12 genes cloned into BamHI site of
pBR322
37
pRU6 E. coli K-12 uxuA gene cloned into SalI site of pBR322 37
pPKL133 2.6-kb KpnI-EcoRI fragment of pPIL38 containing gntP cloned into KpnI-EcoRI
restricted plasmid pGEM3
28
pGEM3 Ampr Promega
pLOF Suicide vector containing mini Tn10::npt 14, 22
TABLE 2. Utilization of various carbohydrates
by E. coli F-18 strains
E. coli strain
Utilization of a:
Glc GlcA GalA Gnt
F-18 1 1 1 1
F-18 fimA::tet 1 1 1 1
F-18 fimA::npt 1 1 1 1
F-18 no. 167 1 1 1 1
F-18 no. 167 uxuA::miniTn10::npt 1 0 1 1
F-18 no. 167
uxuA::miniTn10::npt(pRU1)
1 1 1 1
F-18 no. 167
uxuA::miniTn10::npt(pRU6)
1 1 1 1
F-18(pPKL133) 1 1 1 1
F-18(pGEM3) 1 1 1 1
a Glc, glucose (1.0 mg/ml); GlcA, glucuronate (2.5 mg/ml); GalA, galactur-
onate (2.5 mg/ml); Gnt, gluconate (1.0 mg/ml). Davis minimal agar plates were
incubated at 308C for 48 h.
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intestinal colonization abilities of streptomycin-resistant E. coli strains in mice
has been described previously (13, 34). Briefly, three male, individually housed
CD-1 mice (5 to 8 weeks of age), fed Charles River Valley rat, mouse, and
hamster formula, were given streptomycin-treated (5 g/liter) drinking water for
24 h. Following 18 to 24 h of starvation for food and water, the mice were given
1 ml of 20% (wt/vol) sucrose containing either 1010 or 104 CFU of Luria broth-
grown E. coli strains. The strains were given either alone or along with one or two
other strains. After the bacterial suspension had been ingested, both the food
and streptomycin-treated water were returned to the mice; 1 g of feces was
collected after 5 and 24 h and on odd-numbered days for 2 weeks thereafter.
Cages were changed daily. Fecal samples (no older than 24 h) were homoge-
nized, diluted in 1% tryptone broth, and plated on MacConkey agar (Difco,
Detroit, Mich.) containing antibiotics as indicated in the legends to the figures to
enumerate each E. coli strain. Antibiotic concentrations on plates were as fol-
lows: streptomycin sulfate, 100 mg/ml; rifampin, 50 mg/ml; tetracycline hydro-
chloride, 10 mg/ml; kanamycin, 80 mg/ml; nalidixic acid, 50 mg/ml; ampicillin, 100
mg/ml. All the plates were incubated for 18 to 24 h at 378C before being counted.
Each colonization experiment was performed twice to confirm initial coloniza-
tion results, and the data from both experiments are included in the figures.
Southern blotting. Southern hybridizations were performed at high stringency
with the digoxigenin nonradioactive DNA-labeling and detection kit (Boehringer
Mannheim). The gntP gene of E. coli PC31 (28) was used as the probe.
RESULTS
E. coli F-18 fimA::tet occupies a distinct niche in the mouse
large intestine. The fim gene cluster encodes the genes re-
quired for the synthesis of type 1 fimbriae (26, 27, 33). E. coli
F-18 fimA::tet, unable to make type 1 fimbriae, contains the
chromosomal fim region from the E. coli K-12 strain ORN151
(fimA::tet) (33). As previously described, when mice were fed
1010 CFU each of E. coli F-18 and E. coli F-18 fimA::tet, both
strains colonized at approximately the same level of about 108
CFU/g of feces (34). However, when mice were fed 1010 CFU
of E. coli F-18 and 104 CFU each of E. coli F-18 fimA::tet and
E. coli F-18 Nalr, E. coli F-18 colonized at approximately 108
CFU/g of feces, E. coli F-18 fimA::tet colonized at approxi-
mately 107 CFU/g of feces, and E. coli F-18 Nalr colonized at
approximately 102 CFU/g of feces (Fig. 1). Thus, E. coli F-18
and E. coli F-18 Nalr were equally good colonizers, since they
maintained a ratio of 106:1 throughout the entire 15 days.
However, E. coli F-18 fimA::tet appeared to grow in and occupy
a distinct niche from which E. coli F-18 Nalr was excluded.
When the experiment was performed in the opposite direction,
i.e., when 1010 CFU of E. coli F-18 fimA::tet and 104 CFU of E.
coli F-18 Nalr were fed to mice, E. coli F-18 fimA::tet colonized
at a level of about 108 CFU/g of feces whereas E. coli F-18 Nalr
colonized at about 102 CFU/g of feces (results not shown).
Therefore, E. coli F-18 Nalr was not able to occupy the distinct
niche available to E. coli F-18 fimA::tet. It should be noted that
when occupying the distinct niche, E. coli F-18 fimA::tet was
not only found in feces but was also found in ileal, cecal, and
colonic mucus (not shown).
E. coli F-18 fimA::tet was also able to grow in and occupy the
distinct niche in mice that had been colonized with E. coli F-18
for 15 days. That is, when mice colonized with E. coli F-18 at
a level of about 108 CFU/g of feces were challenged with 104
CFU each of E. coli F-18 fimA::tet and E. coli F-18 Nalr, E. coli
F-18 fimA::tet grew and colonized at a level of about 107 CFU/g
of feces whereas E. coli F-18 Nalr decreased to ,102 CFU/g of
feces (Fig. 2).
In control experiments, it was found that E. coli F-18 fimA::
npt, which does not make type 1 fimbriae because it contains
the fim chromosomal region from E. coli K-12 ORN147
(fimA::npt), and two randomly selected E. coli F-18 P1 trans-
ductants (no. 99 and 167) which contain the fim1 gene cluster
of E. coli ORN152 and which make type 1 fimbriae, were all
able to occupy the distinct niche (data not shown). Therefore,
the ability of E. coli F-18 fim transductants to occupy the
distinct niche was not associated with either tetracycline resis-
tance or the ability to make type 1 fimbriae but appeared to be
due to a fim-linked gene present in the ORN strains that was
either absent or nonfunctional in E. coli F-18. Since the ORN
strains were derived from E. coli K-12, we will refer to the gene
as the K-12 fim-linked gene.
A glucuronate mutant can occupy the distinct site. D-Glu-
curonate is a major constituent of hyaluronic acid, which is
plentiful in mammalian tissues and makes up approximately
0.6% of the dry weight of mouse cecal mucus (28a). The uxu
gene cluster maps downstream of the fim gene cluster at 98
min on the E. coli K-12 chromosome and consists of three
genes, uxuA, which encodes D-mannonate dehydratase (EC
4.2.1.8), uxuB, which encodes D-mannonate oxidoreductase
(EC 1.1.1.57), and uxuR, which encodes a negative repressor of
uxuA and uxuB (48). To determine whether the K-12 fim-
FIG. 1. Colonization of E. coli F-18, E. coli F-18 fimA::tet, and E. coli F-18
Nalr. Six streptomycin-treated mice were fed 1010 CFU of E. coli F-18 (F) and
104 CFU each of E. coli F-18 fimA::tet (E) and E. coli F-18 Nalr (). On the days
indicated, fecal samples were diluted and plated on MacConkey agar containing
streptomycin sulfate and either rifampin, rifampin and tetracycline hydrochlo-
ride, or rifampin and nalidixic acid to differentiate the three strains. Results are
presented as log10 mean CFU per gram of feces6 the standard error (SE) of the
log10 mean.
FIG. 2. Colonization of E. coli F-18 fimA::tet and E. coli F-18 Nalr in mice
precolonized with E. coli F-18. Six streptomycin-treated mice were fed 1010 CFU
of E. coli F-18 (F) and 15 days later were fed 104 CFU each of E. coli F-18
fimA::tet (E) and E. coli F-18 Nalr (n). On the days indicated, fecal samples were
diluted and plated on MacConkey agar containing streptomycin sulfate and
either rifampin, rifampin and tetracycline hydrochloride, or rifampin and nali-
dixic acid to differentiate the three strains. Results are presented as log10 mean
CFU per gram of feces 6 SE of the log10 mean.
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linked gene was involved in glucuronate metabolism, we con-
structed E. coli F-18 no. 167 uxuA::miniTn10::npt, which makes
type 1 fimbriae because it contains the wild-type K-12 fim
gene cluster but is unable to metabolize glucuronate (Tables
1 and 2). Streptomycin-treated mice were fed 1010 CFU of E.
coli F-18 Nalr and 104 CFU of E. coli F-18 no. 167 uxuA::
miniTn10::npt. E. coli F-18 Nalr colonized at about 108 CFU/g
of feces, and E. coli F-18 no. 167 uxuA::miniTn10::npt colo-
nized the distinct niche at between 106 and 107 CFU/g of feces
(data not shown). Therefore, the inability to metabolize glu-
curonate did not abolish the ability to colonize the distinct site.
The K-12 fim-linked gene is gntP. pRU1 contains fimF,
fimG, fimH, gntP, uxuA, and uxuB (see Fig. 5). When mice
were challenged with 1010 CFU of E. coli F-18 Nalr and 104
CFU of E. coli F-18(pRU1), E. coli F-18 Nalr colonized at
about 108 CFU/g of feces and E. coli F-18(pRU1) colonized at
approximately 106 CFU/g of feces (Fig. 3A), indicating that
plasmid pRU1 contains the K-12 fim-linked gene. The only
nonvector gene that pRU6 contains is a functional uxuA gene
(36), which restored glucuronate metabolism to uxuA mutants
(Table 2). When mice were fed 1010 CFU of E. coli F-18 Nalr
and 104 CFU of E. coli F-18(pRU6), E. coli F-18 Nalr colo-
nized at about 108 CFU/g of feces while E. coli F-18(pRU6)
was eliminated from the intestine (i.e., below the detection
limit of 102 CFU/g of feces) (Fig. 3B).
Since the K-12 uxu genes did not appear to be involved in E.
coli F-18 occupying the distinct niche and it was unlikely that
fimF, fimG, and fimH were involved, we tested the possibility
that gntP, the only other K-12 gene on pRU1, was the K-12
fim-linked gene (see Fig. 5). The functional K-12 gntP gene is
the only non-pGEM3 gene on pPKL133 (see Fig. 5). It encodes
a high-affinity gluconate permease (28). When mice were chal-
lenged with 1010 CFU of E. coli F-18 and 104 CFU of E. coli
F-18(pPKL133), E. coli F-18 colonized at about 108 CFU/g of
feces and E. coli F-18(pPKL133) colonized at about 107 CFU/g
of feces (Fig. 4A); i.e., pPKL133 allowed E. coli F-18 to occupy
the distinct niche. In contrast, the vector control pGEM3 did
not allow E. coli F-18 to occupy the distinct niche (Fig. 4B).
These data therefore suggest that the K-12 fim-linked gene
that allows E. coli F-18 to occupy the distinct niche is gntP.
E. coli F-18 does not contain gntP. Southern blotting exper-
iments were performed under high-stringency conditions to
determine whether E. coli F-18 contains gntP. DNA isolated
from both E. coli PC31, a K-12 strain, and E. coli SK22, a
human commensal strain, reacted very strongly with the gntP
probe (1.2-kb NsiI fragment [Fig. 5]), yielding the predicted
6.7-kb fragment released by EcoRV treatment (Fig. 5, lanes 1
and 7), the predicted 5.5-kb fragment released by EcoRI treat-
ment (lanes 2 and 8), and the predicted 1.8-kb fragment con-
FIG. 3. Colonization of E. coli F-18 Nalr, E. coli F-18(pRU1), and E. coli
F-18(pRU6). Six streptomycin-treated mice were fed 1010 CFU of E. coli F-18
Nalr (F) and 104 CFU of E. coli F-18(pRU1) (E) (A) and 1010 CFU of E. coli
F-18 Nalr (F) and 104 CFU of E. coli F-18(pRU6) (E) (B). On the days
indicated, fecal samples were diluted and plated on MacConkey agar plates
containing streptomycin sulfate and either nalidixic acid or ampicillin. Results
are presented as log10 mean CFU per gram of feces 6 SE of the log10 mean.
FIG. 4. Colonization of E. coli F-18 Nalr, E. coli F-18(pPKL133), and E. coli
F-18(pGEM3). Six streptomycin-treated mice were fed 1010 CFU of E. coli F-18
Nalr (F) and 104 CFU of E. coli F-18(pPKL133) (E) (A) and 1010 CFU of E. coli
F-18 Nalr (F) and 104 CFU of E. coli F-18(pGEM3) (E) (B). On the days
indicated, fecal samples were diluted and plated on MacConkey agar plates
containing streptomycin sulfate and either nalidixic acid or ampicillin. Results
are presented as log10 mean CFU per gram of feces 6 SE of the log10 mean.
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taining predominantly gntP DNA released by EcoRI and PstI
treatment (lanes 3 and 9). In contrast, E. coli F-18 DNA re-
acted very weakly with both the 6.7- and 5.5-kb fragments and,
instead of reacting with the expected 1.8-kb gntP fragment,
reacted very weakly with a 0.6-kb EcoRI-PstI fragment (lanes 4
to 6). These results indicate that E. coli F-18 does not contain
a functional gntP gene. In similar Southern blotting experi-
ments, E. coli F-18 fimA::tet was found to contain the gntP gene
(results not shown), suggesting that gntP is also responsible for
its ability to colonize the distinct niche.
DISCUSSION
In a previous report, we suggested that type 1 fimbriae pre-
vent E. coli F-18 from occupying the distinct niche described
here (29); however, in that study, fimA::tet had been bacterio-
phage P1 transduced from an E. coli K-12 strain into E. coli
F-18 and we had not eliminated the possibility that the gene
responsible was not the defective E. coli K-12 fimA::tet gene
but a K-12 fim-linked gene. Here, we show that the effect is due
to the E. coliK-12 gntP gene, which is immediately downstream
of fimH in E. coli K-12 (28) and is not present in E. coli F-18
(Fig. 5). Since gntP encodes a gluconate permease, the distinct
niche is most likely to be a nutritional niche defined by the
presence of gluconate.
As stated above, a major problem encountered in studying
the colonization of the mammalian intestine is what is com-
monly referred to as colonization resistance, in which all in-
testinal niches are occupied in a balanced ecosystem and most
ingested microorganisms fail to colonize because of a lack of
an available niche (30). Colonization resistance is, in fact, the
reason that we used streptomycin, i.e., to clear the mouse
intestine of facultative microorganisms and create an available
niche for our E. coli strains. Streptomycin treatment selectively
reduces the facultative microflora; however, the anaerobic
population in the large intestine remains largely intact, and
large numbers of different species coexist (21). Since E. coli
K-12 fails to colonize the intestines of conventional mice (20),
streptomycin treatment may be eliminating a microorganism
that either utilizes gluconate better than E. coli K-12 does or
kills it.
Gluconate is metabolized in E. coli K-12 via the Entner-
Doudoroff pathway and to a lesser extent via the pentose
phosphate pathway (15, 47). E. coli K-12 contains three glu-
conate permeases other than GntP, each encoded by a differ-
ent gene. The GntI system of genes, which maps at 75 min on
the chromosome, contains gntT and gntU, encoding high- and
low-affinity gluconate transport systems, respectively, and gntK,
encoding a gluconate kinase (24). The GntII system, located at
96 min, contains gntS, encoding a second high-affinity glu-
conate transport system, and gntV, encoding a thermosensitive
gluconate kinase (5). The GntI system is specifically induced by
gluconate and is regulated by gntR, a repressor that also maps
at 75 min (48). GntR also represses the Entner-Douderoff
pathway but does not regulate the genes of the GntII system.
Genes regulating the GntII system have not been identified
(24).
FIG. 5. Southern blotting and E. coli K-12 genes located in pRU1, pRU6, and pPKL133. Equal amounts of genomic DNA isolated from E. coli PC31, F-18, and
SK22 were subjected to restriction enzymes and Southern hybridization as follows: lanes 1 to 3, E. coli PC31 DNA; lanes 4 to 6, E. coli F-18 DNA; lanes 7 to 9, E. coli
SK22 DNA. Lanes 1, 4, and 7 contain DNA cut with EcoRV; lanes 2, 5, and 8 contain DNA cut with EcoRI; lanes 3, 6, and 9 contain DNA cut with EcoRI and PstI.
The digoxigenin-labeled NsiI fragment of gntP was used as the probe. Abbreviations: B, BamHI; E, EcoRI; E5, EcoRV; H, HindIII; K, KpnI; N, NsiI; P, PstI; S, SalI.
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E. coli F-18 does not contain the gntP gene (Fig. 5) but does
metabolize gluconate (Table 2). This suggests that E. coli F-18
has one or more of the gluconate permease genes discussed
above but that these genes are not expressed as well as gntP in
the mouse intestine or that the E. coli F-18 gluconate per-
mease(s) is not as effective as GntP in transporting gluconate
in the intestine.
The E. coli K-12 gntP gene is monocistronic and appears to
be under catabolite repression; i.e., it contains an excellent
catabolite activator protein-binding site and is repressed by
glucose (28). The GntP protein is a high-affinity inner mem-
brane gluconate permease and has a much higher affinity for
gluconate than for a number of other sugars, including glucu-
ronate (28). Interestingly, the expression of gntP is constitutive
in exponentially growing cells in the absence of gluconate or a
catabolite repressing carbon source (28). Moreover, gntP is
repressed by high concentrations of gluconate (28).
The fact that gntP encodes a high-affinity constitutive glu-
conate transport system in the absence of high gluconate con-
centrations suggests that it is ideally suited to function in an
environment containing growth-limiting amounts of gluconate.
The mouse large intestine is most likely to be such an environ-
ment. A primary source of gluconate in the intestine is likely to
be 6-phosphogluconate, which is a key intermediate in the
mammalian and bacterial pentose phosphate pathways (16,
30). We suggest the possibility that as dead epithelial cells are
sloughed from intestinal villus tips into the mucus layer,
6-phosphogluconate is released into the mucus along with dead
epithelial cell contents. The action of presumptive 6-phospho-
gluconate-specific phosphatases present in mucus, of either
epithelial cell or bacterial cell origin, could generate gluconate.
A second gluconate source in the large intestine could of
course be undigested dietary gluconate.
Since gntP is repressed by high concentrations of gluconate
(28), we suggest that gluconate must be present in low con-
centrations in the streptomycin-treated mouse large intestine.
Moreover, we suggest that the E. coli K-12 gntP gene, either in
the chromosome of E. coli F-18 or in a plasmid, allows E. coli
F-18 to utilize growth-limiting amounts of gluconate not only
better than E. coli F-18 but also better than any of the myriad
of other species also present in the streptomycin-treated
mouse large intestine (21). In addition, since E. coli F-18 col-
onizes at about 108 CFU/g of feces and E. coli F-18 carrying the
K-12 gntP colonizes about an order of magnitude lower when
fed in small numbers to mice, E. coli F-18 must be using
something other than gluconate as its major carbon source in
the large intestine.
Finally, the data presented here suggest that at least with
respect to E. coli strains, the nutrient/niche theory is correct.
That is, in the presence of an established E. coli strain, small
numbers of another ingested E. coli strain will grow and colo-
nize as long as it can utilize a growth-limiting nutrient better
than the first E. coli strain and all the other species present in
the intestine.
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